The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Disease
Status
Conditions
Details and patient eligibility
About
The study will include participants who were diagnosed with inflammatory disease and followed up at National Taiwan University Children's Hospital. The investigators will check the NUDT15 gene test, if the participant agrees to do an additional blood test. The result of the gene test will be analyzed and compared with other clinical data.
Full description
In inflammatory bowel disease (IBD), thiopurines play an important role in maintenance of steroid-free remission but possess risk of life-threatening neutropenia, which is associated with gene variants of NUDT15 in Asians. In order to better incorporate thiopurines in clinical practice, the investigators aim to summarize the prevalence and impacts of NUDT15 variation in IBD in Taiwan. The study will include participants who were diagnosed with inflammatory disease and followed up at National Taiwan University Children's Hospital. The investigators will check the NUDT15 gene test, if the participant agrees to do an additional blood test. The result of the gene test will be analyzed and compared with other clinical data.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Participants who are diagnosed with inflammatory bowel disease.
Exclusion criteria
- Participants who refused to have blood test for NUDT15 gene evaluation.
Trial contacts and locations
Loading...
Central trial contact
Jia-Feng Wu, MD, PhD; Wei-Ting Chen, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal